Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $79.99M.
ENTERPRISE VALUE (EV)
$79.99M
Corbus Pharmaceuticals Holdings, Inc.
Market Cap
$108.48M
Enterprise Value (EV)
$79.99M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | $108.48M | $79.99M |
| Apyx Medical Corporation (APYX)vs › | $108.32M | $120.34M |
| Cumberland Pharmaceuticals Inc. (CPIX)vs › | $107.80M | $108.66M |
| Outlook Therapeutics, Inc. (OTLK)vs › | $109.64M | $116.83M |
| Black Diamond Therapeutics, Inc. (BDTX)vs › | $110.02M | $107.80M |
| Immunic, Inc. (IMUX)vs › | $110.43M | N/A |
| BGM Group Ltd. (BGM)vs › | $111.14M | $100.80M |
| Aardvark Therapeutics, Inc. Common Stock (AARD)vs › | $111.39M | $38.22M |
| Definitive Healthcare Corp. (DH)vs › | $105.31M | $101.50M |
| Polaryx Therapeutics, Inc. Common Stock (PLYX)vs › | $104.68M | $93.13M |
Market Cap
$108.48M
Total Debt
$0.00
Cash
$28.49M
Enterprise Value
$79.99M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
